- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Nanomaterials
Volume 2013 (2013), Article ID 867426, 7 pages
Effect of Gold/Fe3O4 Nanoparticles on Biocompatibility and Neural Differentiation of Rat Olfactory Bulb Neural Stem Cells
Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Xue Yuan Road No. 37, Hai Dian District, Beijing 100191, China
Received 13 June 2013; Accepted 30 July 2013
Academic Editor: Xiaoming Li
Copyright © 2013 Menghang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transplantation of stem cells is a potential clinical therapy for repair of central nervous system injury. However, transplanted cells are especially difficult to arrive at the targeted site because of poor survival rate and low efficiency. Recently, gold nanoparticles (NPs) and Iron oxide NPs, as novel nanoparticles, have been used as auxiliary strategy to investigate the nervous system diseases. The present study demonstrates the effect of Gold/Fe3O4 NPs on biocompatibility and differentiated properties of rat olfactory bulb stem cells. Cell viability was assumed by MTT test and cytotoxicity was assessed by Hoechst 33342-PI stain. Cells were cultured at Gold/Fe3O4 NPs concentration range of 40 to 200 μg/104 cells for 24 h. Differentiation was assessed by NSE (a neuronal marker) stain. Results showed that Gold/Fe3O4 NPs at the concentrations of 40 μg/104 cells enhanced cell viability and decreased the cell death rate. Furthermore, the differentiation properties were detected by NSE marker. These findings suggest that Gold/Fe3O4 NPs may thus be used as new nanotechnologies in stem-cell-based transplantation therapies for diagnosis and treatment of central nervous system diseases.
With industrialization of society, central nervous system diseases are becoming an important public health problem . The central nervous system, consisting of spinal cord and brain, is commonly affected by trauma, inflammation, infection, and tumor . Disorders and diseases that injure the central nervous system may produce a variety of symptoms such as paraplegic, quadriplegic, and motor and sensory disorders, which has a significant impact on the quality of life, and the patients’ health became increasingly frail . Therefore, the development of new technologies to repair damaged central nervous system is important for the patients’ quality of life.
Transplantation of stem cells is a potential clinical therapy for repair and regeneration of injured spinal cord or brain. Neural stem cells/neural precursor cells (NSCs/NPCs) derived from the subventricular zone (SVZ)/olfactory bulb (OB) of mammals persist and proliferate throughout life , serving as ideal sources of stem cells for subsequent central nervous system transplantation . However, transplanted cells are especially difficult to migrate in the targeted site because of poor survival rate and low efficiency . Factors proposed for causing such low survival rate include immune reactions, limited trophic factors, and hypoxia , so it appears that developing new technologies to deliver stem cell into transplant site may provide insights into the stem-cell-based therapy.
Recently, the Gold/Fe3O4 NPs become a new research focus because of their magnetic properties, huge surface areas and limited cytotoxicity. However, the study about their properties and applications in neural stem cells therapy is limited. In addition, Gold/Fe3O4 nanoparticles (Gold/Fe3O4 NPs), as magnetic nanoparticles, are being extensively investigated for use as drug carriers and in diagnosis of diseases . Recently, there is accumulating evidence that nanoscale materials can facilitate tissue engineering and stem cell therapy . Restoration of body function is the desire of people with nervous and bone injuries [10–14]. Region-specific cues are important in the neuronal differentiation of stem cells. The process of NSCs toward certain differentiation may be promoted by nanoparticles . Nanotechnology provides a broad range of opportunities to develop new methods for clinical therapy . Therefore, the development of new nanotechnologies to enhance cell survival and differentiation is crucial to stem cell therapy.
In this study, we have introduced novel Gold/Fe3O4 magnetic nanoparticles. The in vitro effects of Gold/Fe3O4 nanoparticles on NPCs were investigated, and cell viability, cytotoxicity, and differentiation were studied.
The Gold/Fe3O4 nanoparticles (50 nm, 5 mg/mL) in an aqueous suspension were obtained from GoldMag Nanobiotech Co. Ltd. (Xi’an, China) . DMEM/F12, basic fibroblast growth factor-2 (bFGF-2), Epidermal growth factor (EGF), and trypsin were obtained from Invitrogen Corp. (CA, USA). Hoechst 33342 and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Monoclonal mouse anti-Nestin, monoclonal mouse anti-NSE, rabbit secondary antibodies conjugated with the fluorescent dye Cy3, and total (rabbit polyclonal antibody) were purchased from Chemicon (USA). Streptomycin and penicillin were purchased from Amresco (USA). Other chemicals used in this study were obtained commercially and were of reagent grade.
2.2. Characterization and Fabrication
Gold/Fe3O4 NPs were prepared as described earlier . The synthesized Gold/Fe3O4 NPs were characterized by scanning electron microscopy (SEM) (FE-SEM, Leon 1530 with EDS) as pervious described methods [18–20].
2.3. Rat NPC Cultures and Characterization
NPCs were prepared from the olfactory bulbs of neonatal Spraguee-Dawley rats. All animals used in the experiments were provided by the animal center of the Peking University. Procedures concerning animals reported in this study were approved by the Committee of Animal Use for Research and Education of Beihang University. All procedures were prepared as described in previously studies . After mechanical dissociation of dissected and pooled olfactory bulbs and enzymatic digestion with 0.125% trypsin, the neurosphere populations were collected. All cells were seeded in DMEM/F12 that was supplemented with streptomycin (50 μg/mL), penicillin (50 U/mL), bFGF (20 ng/mL), and EGF (20 ng/mL). Neural progenitor cells were obtained from at least two passages neurospheres. In experimental conditions (Gold/Fe3O4 NPs at the concentrations of 0, 40, and 200 μg/104 cells), cells were cultured in these media for 24 hours. For the cell lineage analysis, the plates were fixed in 4% cold paraformaldehyde (15 min) and washed (three times, 5 min each) with PBS. The fixed cells were blocked for 30 min in PBS containing 5% normal goat serum and 0.25% Triton X-100, and then incubated overnight at 4°C with primary antibodies diluted in the PBS. Cell types were identified by monoclonal mouse anti-Nestin. Cy3-conjugated secondary antibodies were used to detect the primary antibodies.
2.4. Cell Viability Assay
NPCs were prepared and placed in Gold/Fe3O4 NPs at the concentrations of 0, 40, and 200 μg/104 cells for 24 h. Cell survival was determined by 3-2, 5-diphenyltetrazolium bromide (MTT) (Sigma, USA) assay as previous described methods . Following the treatment, the treated and control NPCs were rinsed three times with PBS. The 200 μL aliquots of NPCs suspension (105/mL) were seeded to three 96-well plates in eight replicates, and 20 μL aliquots of MTT solution (5 mg/mL) were added to each well and incubated for 4 hr in a humidified 5% CO2 incubator at 37°C. The supernatant culture medium was carefully aspirated after centrifuge, and 200 μL aliquots of DMSO were added to each well to dissolve the formazan crystals. ODs were read using 570 nm as a reference wavelength.
2.5. Cytotoxicity Assay
To distinguish between live and dead cells, a staining of nuclei with DNA dyes Hoechust 33342 and propidium iodide was applied as follows. After exposure, pretreated cells were trypsinized, washed with PBS, and stained with propidium iodide (5 μg/mL) and Hoechst 33342 (1 μg/mL) (Sigma, USA) for 10 min at RT. After rinsing in PBS, coverslips were examined using an Olympus BX60 fluorescence microscope equipped with a digital IX 71 camera (Olympus, Tokyo, Japan). Cells were counted, scoring at least 300 cells in 5 microscopic regions randomly selected on each coverslip. The experiments were performed in triplicate.
NPCs were prepared and placed in Gold/Fe3O4 NPs at the concentrations of 0, 40, and 200 μg/104 cells for 24 h. Then treated neurospheres labeled by Hoechst 33342 were transferred to polyornithine-coated glass coverslips. The medium contained 10% fetal bovine serum. After being allowed to differentiate for seven days, the cells were verified by neuronal marker. Half of the medium was replaced every second day. The differentiated cells were fixed in 4% paraformaldehyde and incubated at 4°C overnight with monoclonal mouse anti-NSE.
2.7. Statistical Analysis
The difference between groups was determined with one-way analysis of variance (ANOVA) followed by Tukey’s test using Statistical Package for the Social Sciences (SPSS) 13.0 (SPSS Inc.) software. Differences were considered statistically significant at .
3.1. Characterization of Gold/Fe3O4 NPs
Figure 1 displays the scanning electron microscopy (SEM) photograph of Gold/Fe3O4 NPs showing that Gold/Fe3O4 NPs were spherical-like, well-dispersed, uniformed in size and shape, and about 50 nm in diameter.
3.2. Isolation and Characterization of NPC
Newborn rat brains were removed and the olfactory bulbs were dissected. Neural precursor cells were obtained from olfactory bulb tissue. After 3–7 days in culture, the NPCs displayed rounded spherical cells which were dividing and forming cell spheres or aggregates (Figure 2(a)). Cell types were identified by monoclonal mouse anti-Nestin, markers of neuroepithelial stem cells (Figure 2(b)).
3.3. Low Concentration of Gold/Fe3O4 NPs Increases NPC Cell Viability
NPCs were prepared and placed in Gold/Fe3O4 NPs at the concentrations of 0, 40, and 200 μg/104 cells for 24 h. The in vitro effect of 24 h of Gold/Fe3O4 NPs on NPC viability was assessed. The results of an MTT assay indicated that 40 μg/104 cells group increased the cell viability of NPCs. Cells cultured in 200 μg/104 cells group showed lower cell viability than other groups (Figure 3).
The NPCs cultured in 200 μg/104 cells group resulted in a remarkable decrease in cell viability. But in the 40 μg/104 cells group, cell viability was higher. Therefore we presumed that the concentration of Gold/Fe3O4 NPs might play an important role in cell survival and death of exogenous stem cells.
3.4. Low Concentration of Gold/Fe3O4 NPs Decreases Cell Death Rate of NPC
In order to investigate the cytotoxicity properties of NPCs after 24 h exposure to Gold/Fe3O4 NPs, staining with Hoechst 33342 and propidium iodide (PI) was used so that the number of dead cells (PI-positive) could be expressed as a percentage of total cells. Thus, the percentage of dead cells of the low concentration of Gold/Fe3O4 NPs (at the concentrations of 40 μg/104 cells) was decreased compared with the control (Figures 4(a) and 4(b)). At the concentrations of 200 μg/104 cells group, an increase in the cell death rate. Thus, concentration range of external Gold/Fe3O4 NPs affect the cell survival and death.
3.5. Low Concentration of Gold/Fe3O4 NPs Enhances NPC Differentiation
With immunohistochemical staining, the differentiation of NPCs was studied through the use of markers of differentiated cells, NSE (a neuron-specific enolase) . In comparsion with control group, more cells were stained by NSE of the low concentration of Gold/Fe3O4 NPs (at the concentrations of 40 μg/104 cells) (Figure 5).
The expression of NSE has been detected in olfactory stem cells; the NSE levels implicate a crucial role as a regulator of neuronal differentiation in stem cell.
In our study, Gold/Fe3O4 NPs of low concentration group, at the concentrations of 40 μg/104 cells, resulted in a remarkable enhanced cell viability, a decrease in the cell death rate, and enhancement of neuronal differentiation. Surprisingly, when the concentration of Gold/Fe3O4 NPs was raised to 200 μg/104 cells, the death rates began to increase. Furthermore, the differentiation properties were enhanced at low concentration group. These findings suggest that Gold/Fe3O4 NPs may thus be used as new nanotechnologies in stem-cell-based transplantation therapies for diagnosis and treatment of central nervous system diseases.
Stem-cell-based therapy provides the potential for repair and regeneration of damaged neural tissue in the therapy of central nervous system injury. OB NPCs derived from olfactory bulb tissue are accessible and abundant sources of stem cells for translational clinical research and can be differentiated into multiple cell lineages, including chondrocytes, myocytes, and neuronal cells . Compared with other stem cells, OB NPCs are superior seed cells for autologous cell transplantation in promoting nerve regeneration, as they can be obtained by less invasive procedures and cultured with higher proliferation rates . Recently, OB NPCs have emerged as an alternative treatment option for degenerative spinal cord disease and CNS degeneration disease [5, 25, 26]. Therefore, the OB NPCs have important merits in regenerative clinical application and can be considered as a strategy for future tissue engineering.
Gold/Fe3O4 NPs also represent an interesting tool for MRI measurement and cancer therapy . However, the role of these Gold/Fe3O4 NPs in the mammalian central nervous system is still unclear. This study has shown that concentration range of external Gold/Fe3O4 NPs was found to participate in regulation of stem cells survival and death. The findings may provide insight into future efforts to cell-based transplantation therapy. The application of this new technology will further depend on scientific and technological progress that does not depend on painful invasive procedures.
The differentiation properties induced by Gold/Fe3O4 NPs were detected by NSE marker. NSE is widely recognized as a neuron differentiation marker. Neuron-astrocyte interactions play a leading role in the differentiation of NPCs, and a recent study showed that NSE-positive neurons can participate in the regulation of neurogenesis . Region-specific cues are important in the neuronal differentiation of the original NPCs. Recently, tissue engineering has focused on the importance of developing in vitro stem cell microenvironment for transplanted cells proliferation and tissue-specific differentiation [29–32]. The present study revealed that certain factors “guide” NPCs towards certain differentiation and that the process may be promoted by Gold/Fe3O4 NPs.
The present study demonstrates that Gold/Fe3O4 NPs may be used as an auxiliary strategy and might play an important role in the stem cell transplantation therapies. Although our work suggested that concentration range of external Gold/Fe3O4 NPs was found to participate in regulation of stem cells survival and death, future research efforts focus on the mechanism of Gold/Fe3O4 NPs and stem cells remained to be elucidated.
Conflict of Interests
The authors indicate no potential conflict of interests.
Menghang Wang and Zhou Li contributed equally to this study.
This study was supported in part by grants from the National Basic Research Program of China (973 program, 2011CB710901), National Natural Scientific Foundation of China (NSFC nos. 11120101001, 10925208, 11202018, 81101123 and 31200702), and the Postdoctoral Science Foundation of China (20110490269 and 2013T60055).
- A. Poduri, G. D. Evrony, X. Cai, and C. A. Walsh, “Somatic mutation, genomic variation, and neurological disease,” Science, vol. 341, no. 6141, Article ID 123775, 2013.
- D. Galimberti and E. Scarpini, “Alzheimer's disease: from pathogenesis to disease-modifying approaches,” CNS and Neurological Disorders, vol. 10, no. 2, pp. 163–174, 2011.
- A. C. Evangelista Santos Barcelos, F. B. Scardino, G. C. Patriota, J. M. Rotta, and R. V. Botelho, “Paraparesis or incomplete paraplegia? How should we call it?” Acta Neurochirurgica, vol. 151, no. 4, pp. 369–372, 2009.
- J. M. Garcia-Verdugo, F. Doetsch, H. Wichterle, D. A. Lim, and A. Alvarez-Buylla, “Architecture and cell types of the adult subventricular zone: in search of the stem cells,” Journal of Neurobiology, vol. 36, no. 2, pp. 234–248, 1998.
- A. Björklund and O. Lindvall, “Cell replacement therapies for central nervous system disorders,” Nature Neuroscience, vol. 3, no. 6, pp. 537–544, 2000.
- X. Zeng, S. P. Yu, T. Taylor, M. Ogle, and L. Wei, “Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis,” Stem Cell Research, vol. 8, no. 3, pp. 357–367, 2012.
- M. H. Theus, L. Wei, L. Cui et al., “In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain,” Experimental Neurology, vol. 210, no. 2, pp. 656–670, 2008.
- X. Chao, Z. Zhang, L. Guo et al., “A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy,” PLoS One, vol. 7, no. 10, Article ID e40388, 2012.
- S. Y. Park, J. Park, S. H. Sim et al., “Enhanced differentiation of human neural stem cells into neurons on graphene,” Advanced Materials, vol. 23, no. 36, pp. H263–H267, 2011.
- X. Li, Y. Huang, L. Zheng et al., “Effect of substrate stiffness on the functions of rat bone marrow and adipose tissue derived mesenchymal stem cells in vitro,” Journal of Biomedical Materials Research A, 2013.
- X. Li, C. A. van Blitterswijk, Q. Feng, F. Cui, and F. Watari, “The effect of calcium phosphate microstructure on bone-related cells in vitro,” Biomaterials, vol. 29, no. 23, pp. 3306–3316, 2008.
- X. Li, L. Wang, Y. Fan, Q. Feng, F. Z. Cui, and F. Watari, “Nanostructured scaffolds for bone tissue engineering,” Journal of Biomedical Materials Research A, vol. 101, no. 8, pp. 2424–2435, 2013.
- X. Li, H. Liu, X. Niu et al., “Osteogenic differentiation of human adipose-derived stem cells induced by osteoinductive calcium phosphate ceramics,” Journal of Biomedical Materials Research B, vol. 97, no. 1, pp. 10–19, 2011.
- X. Li, Q. Feng, X. Liu, W. Dong, and F. Cui, “Collagen-based implants reinforced by chitin fibres in a goat shank bone defect model,” Biomaterials, vol. 27, no. 9, pp. 1917–1923, 2006.
- Y. Liu, G. Wang, Y. Cai et al., “In vitro effects of nanophase hydroxyapatite particles on proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells,” Journal of Biomedical Materials Research A, vol. 90, no. 4, pp. 1083–1091, 2009.
- D. B. Buxton, “Nanomedicine for the management of lung and blood diseases,” Nanomedicine, vol. 4, no. 3, pp. 331–339, 2009.
- W. Hui, F. Shi, K. Yan et al., “Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation,” Nanoscale, vol. 4, no. 3, pp. 747–751, 2012.
- X. Li, X. Liu, W. Dong et al., “In vitro evaluation of porous poly(L-lactic acid) scaffold reinforced by chitin fibers,” Journal of Biomedical Materials Research B, vol. 90, no. 2, pp. 503–509, 2009.
- X. Li, H. Gao, M. Uo et al., “Effect of carbon nanotubes on cellular functions in vitro,” Journal of Biomedical Materials Research A, vol. 91, no. 1, pp. 132–139, 2009.
- X. Li, H. Gao, M. Uo et al., “Maturation of osteoblast-like SaoS2 induced by carbon nanotubes,” Biomedical Materials, vol. 4, no. 1, Article ID 015005, 2009.
- M. Wang, J. Qiu, W. Mi, F. Wang, and J. Qu, “In vitro effect of altering potassium concentration in artificial endolymph on apoptosis and ultrastructure features of olfactory bulb neural precursor cells,” Neuroscience Letters, vol. 487, no. 3, pp. 383–388, 2011.
- X. Li, Y. Yang, Y. Fan, Q. Feng, F. Z. Cui, and F. Watari, “Biocomposites reinforced by fibers or tubes as scaffolds for tissue engineering or regenerative medicine,” Journal of Biomedical Materials Research A, 2013.
- M. C. Whitman and C. A. Greer, “Adult neurogenesis and the olfactory system,” Progress in Neurobiology, vol. 89, no. 2, pp. 162–175, 2009.
- C. Vicario-Abejón, M. J. Yusta-Boyo, C. Fernández-Moreno, and F. de Pablo, “Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia,” Journal of Neuroscience, vol. 23, no. 3, pp. 895–906, 2003.
- A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall, “Neuronal replacement from endogenous precursors in the adult brain after stroke,” Nature Medicine, vol. 8, no. 9, pp. 963–970, 2002.
- C. V. Borlongan, “Recent preclinical evidence advancing cell therapy for Alzheimer's disease,” Experimental Neurology, vol. 237, no. 1, pp. 142–146, 2012.
- J. Ma, Y. Shen, S. Stojicic, and M. Haapasalo, “Biocompatibility of two novel root repair materials,” Journal of Endodontics, vol. 37, no. 6, pp. 793–798, 2011.
- A. Bharosay, V. V. Bharosay, M. Varma, K. Saxena, A. Sodani, and R. Saxena, “Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke,” Indian Journal of Clinical Biochemistry, vol. 27, no. 2, pp. 186–190, 2012.
- X. Li, H. Liu, X. Niu et al., “The use of carbon nanotubes to induce osteogenic differentiation of human adipose-derived MSCs in vitro and ectopic bone formation in vivo,” Biomaterials, vol. 33, no. 19, pp. 4818–4827, 2012.
- X. Li, L. Wang, Y. Fan, Q. Feng, and F. Cui, “Biocompatibility and toxicity of nanoparticles and nanotubes,” Journal of Nanomaterialsno, vol. 2012, Article ID 548389, 19 pages, 2012.
- X. Li, Y. Fan, and F. Watari, “Current investigations into carbon nanotubes for biomedical application,” Biomedical Materials, vol. 5, no. 2, Article ID 022001, 2010.
- X. Li, X. Liu, J. Huang, Y. Fan, and F.-Z. Cui, “Biomedical investigation of CNT based coatings,” Surface and Coatings Technology, vol. 206, no. 4, pp. 759–766, 2011.